Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-18-000700

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Fink Jeffrey Arvin Director 2018-06-27 Grant or award · Stock Option (Right to Buy) +20,000 $1.33 $26,600 20,000 D
Loading xslF345X03/doc4_5502.xml…